Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

127 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    The Council Of The European Union Votes In Favor Of Amending The Transitional Provisions In The MDR And IVDR

    The extension of the transitional periods in the MDR and the removal of the "sell-off" deadline in the MDR and the IVDR were approved by the Council of the EU today.
    European UnionFood, Drugs, Healthcare, Life Sciences
    Cooley LLP
    Cooley LLP
  • Article

    CMS Releases Annual Health Insurance Exchanges Final Rule

    On April 9, 2018, the Centers for Medicare & Medicaid Services (CMS) released the Benefit and Payment Parameters final rule for 2019 (2019 Payment Notice) applicable to qualified health plans (QHPs) ...
    BelgiumFood, Drugs, Healthcare, Life Sciences
    Hogan Lovells
    Hogan Lovells
  • Article

    Commission Communication On Biotechnology And Biomanufacturing

    On 20 March, the Commission proposed several measures intending to boost technology and biomanufacturing in the EU, including the Commission Communication...
    European UnionFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    New EU Sample Retention Rules Coming Up For Veterinary Medicines Repackaged For Parallel Trade

    The Veterinary Medicinal Products Regulation (EU) 2019/6 has applied in the EU since 28 January 2022, replacing Directive 2001/82/EC. The new rules on good manufacturing practice (GMP) will in turn...
    European UnionFood, Drugs, Healthcare, Life Sciences
    ALTIUS
    ALTIUS
  • Article

    Updates To The EU Pharmacovigilance Rules: Key Takeaways For Marketing Authorisation Holders

    On 22 July 2025, the European Commission adopted Implementing Regulation (EU) 2025/1466 ("Regulation"), updating the EU pharmacovigilance (or "PV") rules by way of amendments...
    European UnionFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    English Court Orders Disclosure Of Customer Information At Interim Stage

    On 28 February, the High Court handed down an interim judgment in Eli Lilly v Neopharma and Anor (Howrey acting for Eli Lilly) in which it ordered the disclosure of information relating to sales of the (allegedly) infringing pharmaceutical Olanzapine Neopharma.
    BelgiumIntellectual Property
    Howrey LLP
    Howrey LLP
  • Article

    Regulatory Pulse Pharma And Medical Devices Newsletter: Issue #3

    The European Health Data Space Regulation (EHDS Regulation) entered into force on March 26, 2025. The purpose of the Regulation is to establish a common framework for the use and exchange...
    European UnionFood, Drugs, Healthcare, Life Sciences
    Steptoe LLP
    Steptoe LLP
  • Article

    Nanotechnologies — Latest Developments

    Nanotechnologies are heralded as the basis for the ‘next industrial revolution’, with their commercial use growing exponentially.
    European UnionEnvironment
    Steptoe LLP
    Steptoe LLP
  • Article

    EU Consults On New GMP Rules For AI In Pharma Manufacturing

    On 7 July 2025, the European Commission launched a public consultation that could mark the start of a turning point for how Artificial Intelligence (AI) is used in pharmaceutical manufacturing.
    European UnionTechnology
    Arnold & Porter
    Arnold & Porter
  • Article

    CJEU Rules On GDPR Access Rights And Abuse Of Rights: What The Brillen Rottler Judgment Means For Life Sciences Companies

    On 19 March 2026, the Court of Justice of the European Union (CJEU or Court) issued its judgment in Case C-526/24, Brillen Rottler GmbH & Co. KG v TC.
    BelgiumFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    The New Product Liability Directive

    The new Product Liability Directive ("PLD") replaced the old Product Liability Directive (Directive 85/375/EEC) and aims to bring the European Union's product liability regime...
    BelgiumConsumer Protection
    ALTIUS
    ALTIUS
  • Article

    Belgium Aims For Hospitals To Increase Their Biosimilars Uptake

    On 22 September 2023, the Royal Decree of 13 September 2023 establishing specific rules on the public procurement of biological medicinal products was published in the Belgian State Gazette...
    BelgiumFood, Drugs, Healthcare, Life Sciences
    ALTIUS
    ALTIUS
  • Article

    IoT In The EU: Lessons From COVID-19, And Next Steps For Liability And Regulation

    The IoT sector has exploded over the past few years, and, even taking into account the globally inhibitive effects of COVID-19, this growth shows few long-term signs of abating.
    European UnionAntitrust/Competition Law
    Hogan Lovells
    Hogan Lovells
  • Article

    GMOs: A Principle Established With…Precaution

    In the midst of the debate over the co-existence of traditional and GM crops, the Court of Justice of the European Union (ECJ) has delivered two very important judgments in the space of a few days.
    European UnionFood, Drugs, Healthcare, Life Sciences
    Van Bael & Bellis
    Van Bael & Bellis
  • Article

    Medical Devices Regulation

    The EU Medical devices Regulation Cooley's Productwise Bitesize brings you a short overview of the EU Medical Devices Regulation.
    European UnionFood, Drugs, Healthcare, Life Sciences
    Cooley LLP
    Cooley LLP
  • Article

    REACH Obligation To Register Imported Chemicals May Be Assumed By A Person Other Than The Buyer

    Under the EU's REACH Regulation 1907/2006, substances must be registered with the European Chemicals Agency before being imported.
    European UnionFood, Drugs, Healthcare, Life Sciences
    ALTIUS
    ALTIUS
  • Article

    European Commission Publishes New Variation Guidelines For Medicines

    The European Commission has published new Guidelines on the details of the various categories of variations (to the terms of marketing authorisations ("MA") for medicinal products) ("Variations Guidelines").
    European UnionFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    Belgium’s Healthcare Plans For 2026 – And Where Pharma Fits In

    Every year, Belgium’s federal ministers publish their policy notes for discussion in Parliament. They give a high-level snapshot of what each minister plans to focus on in the coming year.
    BelgiumFood, Drugs, Healthcare, Life Sciences
    ALTIUS
    ALTIUS
  • Article

    EMA Guidance On Comparability Exercise For ATMPs

    On 13 December 2019, the European Medicines Agency ("EMA") published a Questions and Answers document ("Q&A")
    BelgiumFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    EU AI Act Omnibus: Provisional Deal Announced – Initial Reflections For Life Sciences Companies

    The European Parliament and Council have reached a provisional agreement on reforms to the EU AI Act, introducing extended compliance deadlines and clarifications for high-risk AI systems.
    BelgiumFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Showing 41–60 of 127 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics